ELİF TUĞÇE ERDEVE, FİLİZ ONAT, NİHAN ÇARÇAK
Archives of Epilepsy - 2025;31(3):77-82
Objective: Levetiracetam (LEV) is a broad-spectrum anti-seizure drug primarily prescribed for partial seizures. We aimed to compare the effects of LEV in two epilepsy models: the kindling model for temporal lobe epilepsy and the Genetic Absence Epilepsy Rats from Strasbourg (GAERS) model for absence epilepsy
